CN1219425A - Medicine for curing rheumatic and rheumatoid arthritis and its preparation method - Google Patents

Medicine for curing rheumatic and rheumatoid arthritis and its preparation method Download PDF

Info

Publication number
CN1219425A
CN1219425A CN 98124813 CN98124813A CN1219425A CN 1219425 A CN1219425 A CN 1219425A CN 98124813 CN98124813 CN 98124813 CN 98124813 A CN98124813 A CN 98124813A CN 1219425 A CN1219425 A CN 1219425A
Authority
CN
China
Prior art keywords
medicine
rheumatoid arthritis
maltose
radix
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98124813
Other languages
Chinese (zh)
Inventor
郝玉凤
郝帅
郝丹
郝彬
Original Assignee
郝玉凤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 郝玉凤 filed Critical 郝玉凤
Priority to CN 98124813 priority Critical patent/CN1219425A/en
Publication of CN1219425A publication Critical patent/CN1219425A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine in the form of pills for curing rheumatic arthritis and rheumatoid arthritis is prepared from 11 Chinese medicinal materials such as prepared semen strychni, tuckahoe, eucommia bark, dahurian angelica root, musk, yam,malt extract, etc through selection, baking, grinding, sieving, high-pressure sterilization, mixing, making pills with maltose and sealing (such as wax sealing), and features short course of treatment, high curative effect (effective rate of 95% and cure rate of 84.24%), low cost and no toxic by-effect.

Description

A kind of medicine and manufacture method for the treatment of rheumatism and rheumatoid arthritis
The invention belongs to the field of Chinese herbal feature relates to Chinese medicine medicines and treats rheumatism, the prescription of medicine for treating rheumatoid arthritis and compound method thereof.
Rheumatic arthritis is the systemic disease that is caused by first family beta hemolytic streptococcus, and the traditional Chinese medical science belongs to " arthromyodynia " category.
Rheumatoid arthritis is a kind of by due to the streptococcal infection, based on the chronic golden body immune disease of arthropathy, is one of modern difficult treatment.The traditional Chinese medical science belongs to " insensitive impediment ", " rheumatoid arthritis ", " rheumatism involving the bone " category.
Treat rheumatism at present, the medicine of rheumatoid arthritis also has many as the Radix Tripterygii Wilfordii sheet in this world, and curative effect of medication such as WANGBI CHONGJI are not ideal.Application number is 93106417.1 by literature search, (treating rheumatoid Chinese patent medicine Jinlongkang and manufacture method thereof), its clinical effective rate reaches 98.5%, side effect simultaneously is little, and the clinical cooperation local skin acupuncture of application number 93102233 (numbness is led to external medicinal liquid) treats rheumatism and rheumatoid arthritis all has significant curative effect.
No matter treatment rheumatism and rheumatoid arthritis adopt method traditional Chinese medical science doctor trained in Western medicine all undesirable with external application or its curative effect of endo-medicine usually both at home and abroad at present, toxic and side effects is big, waits deficiency, and the local acupuncture of clinical cooperation is treated inconvenient, and the efficacy of a drug short uncertain therapeutic efficacy action time is cut.
In order to overcome original technical shortcoming, the objective of the invention is to develop that a kind of pure Chinese medicine for oral administration is treated rheumatism and rheumatoid arthritis reaches the curative effect height, alleviate patient's slight illness, low economic convenient and easy, the safe and reliable purpose of cost.
Take following technical measures for realizing purpose of the present invention.
A kind of endo-medicine for the treatment of rheumatism and rheumatoid arthritis, its prescription is: Semen Strychni (processed) 10-20g, Rhizoma Chuanxiong 10-20g, Radix Rehmanniae Preparata 10-20g, Poria 10-20g, Cortex Eucommiae 10-20g, Radix Achyranthis Bidentatae 10-20g, Radix Angelicae Dahuricae 10-20g, Auricularia 450-510g, Moschus 0.2-0.6g, Rhizoma Dioscoreae 5-15g, maltose 450-510g.
Preparation technology's method of medicine is that the required Chinese medicine of respectively distinguishing the flavor of is dried, grinds, sieved, high sterilization mixes to stir evenly and be fine flour through choosing in will filling a prescription earlier, is that ball is done 80 balls altogether and sealed then and promptly get product after (encapsulating as the wax shell) packs with maltose.
The property of medicine of above-mentioned flavor medicine and effect:
Semen Strychni (processed): heat in blood, reducing swelling and alleviating pain loose.
Rhizoma Chuanxiong: activating QI to alleviate the depression, dispeiling pathogenic wind and removing dampness, promoting blood circulation and stopping pain.
Radix Rehmanniae Preparata: deficiency of YIN impairment caused by overstrain, waist soreness.
Maltose: easing middle-JIAO and tonifying for deficiency, promote the production of body fluid and moisturize.
Poria: eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.
Radix Achyranthis Bidentatae: dissipating blood stasis blood, the pain that disappears swell.
Rhizoma Dioscoreae: strengthening the spleen and tonifying the lung, the benefit of reinforcing the kidney essence.
Auricularia: cooling blood for hemostasis.
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening.
The Radix Angelicae Dahuricae: dispeiling pathogenic wind and removing dampness, reducing swelling and alleviating pain.
Moschus: have one's ideas straightened out and ward off dirty, collateral dredging dissipating blood stasis.
Wherein Semen Strychni (processed) is that monarch drug, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Auricularia, Radix Achyranthis Bidentatae are that ministerial drug, Radix Rehmanniae Preparata, maltose, Poria, the Cortex Eucommiae are that adjuvant drug, Moschus are messenger drug, and all medicines share common crowd and play, and the promoting blood circulation to remove blood stasis detumescence is dispeled the wind, muscles and tendons relaxing to alleviate pain to be to reach therapeutic purposes.
Usage and consumption: one time one ball, clothes secondary on the one send down with yellow wine.
Taboo: Aqua Folium Camelliae sinensis, liquorice beverage, cold water.
1 of case * *, the man, 37 years old, Hulan, Heilongjiang Province city peasant, examined in 1980 13 days and suffered from rheumatoid arthritis 7 years, state of an illness aggravation in recent years, is deformed into typical spina ventosa, limitation of activity at the swelling of both hands wrist articulations digitorum manus, pain, amyotrophy, can't take care of oneself, it is positive to look into rheumatoid factor test, and the film making of X line shows that both hands refer to and ankle joint all has the rheumatoid arthritis sample to change.Take this medicine arthralgia 2 courses of treatment, symptoms such as swelling are obviously improved, and function of joint also has obvious recovery, looks into rheumatoid factor negative, and the work that promptly recovered 3 courses of treatment is taken in the life of can taking care of oneself, and recurrence was not seen in drug withdrawal in 1 year.
Case 2: Korea Spro * *, the woman, 56 years old, Changli County, Hebei province peasant, on January 10th, 1997 examined, suffer from rheumatoid arthritis, 15 years, the both hands little finger of toe, middle finger, the migration of thumb joint is swollen and ache, stiff, can not bend and stretch, emaciated physique, joint of the lower extremity pain, pain concentrates on two joint of the lower extremity gradually, especially with two knee joints for very, contracture can not be stretched, and looks into the rheumatoid factor positive, and the film making of X line shows the both hands wrist, refer to and ankle joint, double knee joint all has the rheumatoid joint sample to change, only knee joint enlargement shape such as crane knee joint, lower limb is thin has up and down become the disabled person as bavin, can't take care of oneself, 2 courses of treatment of upper and lower extremities gradually takes this medicine, knee joint is can be back and forth movable, to the symptom commentaries on classics of getting better greatly such as stretching, and the 3-5 of clothes course of treatment, look into rheumatoid factor negative, all symptoms are all improved until clinical cure (indicating 40 days course of treatment)
This group case is commented according to 7 diagnostic criterias of Americanism damp disease association revision in 1997 and is ordered, and the present invention is as follows from 330 routine rheumatism and the clinical observation of rheumatoid arthritis treatment effect:
Male: 98 examples, women's 232 examples, age 18-55 year, average 35.5 years old, cure (clinical symptom disappearance, rheumatoid factor is turned out cloudy, erythrocyte sedimentation rate descends normal) 278 routine produce effects (obviously improve by clinical symptoms, stiff 15 meters walking times of time in morning, erythrocyte sedimentation rate descends 60%), 310 examples; Effective (clinical symptoms improve erythrocyte sedimentation rate descend 40%) 20 examples, effective percentage 95%, cure rate 84.24%.
Advantage of the present invention:
Pure treatment by Chinese herbs rheumatism and rheumatoid arthritis endo-medicine, short treating period, curative effect height, effective percentage 95%, cure rate 84.24%, this medicine cost is low, has no side effect.
Most preferred embodiment: the prescription of its medicine is: Semen Strychni (processed) 13g, Rhizoma Chuanxiong 13g, Radix Rehmanniae Preparata 13g, Poria 13g, Cortex Eucommiae 13g, Radix Achyranthis Bidentatae 13g, Radix Angelicae Dahuricae 13g, Auricularia 480g, Moschus 0.2g, Rhizoma Dioscoreae 12g, maltose 510g.
Processing technique is will fill a prescription the required Chinese medicine of respectively distinguishing the flavor of earlier through the choosing oven dry, grinds, and sieves, and the autoclaving mixing stirs evenly, and is fine flour, is ball with maltose, does altogether promptly getting product after 80 balls seal (as the encapsulation of wax shell) packing then.

Claims (3)

1, a kind of medicine for the treatment of rheumatism and rheumatoid arthritis, it is characterized in that it contains Semen Strychni (processed) 10-20g, Rhizoma Chuanxiong 10-20g, Radix Rehmanniae Preparata 10-20g, Poria 10-20g, Cortex Eucommiae 10-20g, Radix Achyranthis Bidentatae 10-20g, Radix Angelicae Dahuricae 10-20g, Auricularia 450-510g, Moschus 0.2-0.6g, Rhizoma Dioscoreae 5-15g, maltose 450-510g.
2, medicine according to claim 1 is characterized in that Semen Strychni (processed) 10-20g, Poria 10-20g, Cortex Eucommiae 10-20g, Radix Achyranthis Bidentatae 10-20g, Radix Angelicae Dahuricae 10-20g, Auricularia 450-510g, Moschus 0.2-0.6g, Rhizoma Dioscoreae 5-15g, maltose 450-510g, Rhizoma Chuanxiong 10-20g, Radix Rehmanniae Preparata 10-20g.
3, a kind of preparation method for the treatment of rheumatism and medicine for treating rheumatoid arthritis is characterized in that its prescription is Semen Strychni (processed) 13g, Rhizoma Chuanxiong 13g, Radix Rehmanniae Preparata 13g, Poria 13g, Cortex Eucommiae 13g, Radix Achyranthis Bidentatae 13g, Radix Angelicae Dahuricae 13g, Auricularia 480g, Moschus 0.2g, Rhizoma Dioscoreae 12g, maltose 510g.
Processing technique is that the required Chinese medicine of respectively distinguishing the flavor of is through choosing in will filling a prescription earlier, and oven dry grinds, and sieves, and autoclaving mixes to stir evenly and is fine flour, is that ball is done 80 balls altogether with maltose, promptly gets product after sealing then (as the encapsulation of wax shell) is packed.
CN 98124813 1998-11-13 1998-11-13 Medicine for curing rheumatic and rheumatoid arthritis and its preparation method Pending CN1219425A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98124813 CN1219425A (en) 1998-11-13 1998-11-13 Medicine for curing rheumatic and rheumatoid arthritis and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98124813 CN1219425A (en) 1998-11-13 1998-11-13 Medicine for curing rheumatic and rheumatoid arthritis and its preparation method

Publications (1)

Publication Number Publication Date
CN1219425A true CN1219425A (en) 1999-06-16

Family

ID=5228826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98124813 Pending CN1219425A (en) 1998-11-13 1998-11-13 Medicine for curing rheumatic and rheumatoid arthritis and its preparation method

Country Status (1)

Country Link
CN (1) CN1219425A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425243C (en) * 2005-08-19 2008-10-15 李斌 Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis
CN102600345A (en) * 2012-04-19 2012-07-25 张生 Traditional Chinese medicine for treating rheumatic lumbocrural pain

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425243C (en) * 2005-08-19 2008-10-15 李斌 Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis
CN102600345A (en) * 2012-04-19 2012-07-25 张生 Traditional Chinese medicine for treating rheumatic lumbocrural pain
CN102600345B (en) * 2012-04-19 2013-06-26 姜喜 Traditional Chinese medicine for treating rheumatic lumbocrural pain

Similar Documents

Publication Publication Date Title
CN1899563A (en) Medicinal wine for treating trachitis and pulmonary emphysema dyspneic cough
CN1290565C (en) Sichuan China berry anti-inflammation oral liquor
CN1062157C (en) Hepatitis B curing toxin-dissipating pill
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN101670011A (en) Medicament for treating rheumatism and rheumatoid and preparation method thereof
CN1850237A (en) Medicine for treating chronic superficial gastritis and peptic ulcer diseases
CN103861001A (en) Traditional Chinese medicines for treating epidemic hemorrhagic fever
CN101062274A (en) Medicine for treating amenorrhea and preparing method thereof
CN101390993B (en) Traditional Chinese medicine for treating diabetic foot
CN101810807B (en) Chinese medicinal liquor for treating rheumatoid arthritis and preparation method thereof
CN1219425A (en) Medicine for curing rheumatic and rheumatoid arthritis and its preparation method
CN1055220C (en) Chinese drug for treatment of hemiplegia
CN101632831B (en) Traditional Chinese medicine medicated wine for treating waist and leg pains
CN101062236A (en) Astragalus radix pseudostell oral liquid
CN102641391A (en) Chinese wolfberry fruit fat reducing and liver nourishing pill
CN102512543A (en) Chinese medicinal composition for treating rheumatoid arthritis
CN102430057B (en) Medicinal composition for treating rheumatic pain
CN101444616B (en) Medicated wine for curing chronic rheumatism and method for preparing same
CN1171967A (en) Medicinal liquid Yuyepizhengke for curing rheumatic arthritis
CN106309921A (en) Capsule medicine for treating liver-kidney yin deficiency and yin blood deficiency and preparation method thereof
CN1259086C (en) Bizhengkang-treating arthromyodynia
CN117503872A (en) A Chinese medicinal composition for treating gastric ulcer, stomach ache and gastrectasia, and its preparation method
CN104435178A (en) Oral medicine for treating rheumatoid arthritis, and preparation method thereof
CN103610906A (en) Pharmaceutical composition for treating pain from rheumatism
CN103381252B (en) Traditional Chinese medicine composition for treating rheumatoid arthritis, and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication